Targeted molecular medicine: advances in the treatment of metastatic phaeochromocytoma and paraganglioma

Lancet. 2024 Mar 16;403(10431):1001-1003. doi: 10.1016/S0140-6736(23)02828-3. Epub 2024 Feb 22.

Authors

Mitsuhide Naruse¹, William F Young Jr²

Affiliations

¹ Endocrine Center and Clinical Research Center, Ijinkai Takeda General Hospital, Kyoto 601-1495, Japan. Electronic address: mtsnaruse@gmail.com.
² Division of Endocrinology, Diabetes, Metabolism, and Nutrition, Mayo Clinic College of Medicine and Science, Rochester, MN, USA.

PMID: 38402884
DOI: 10.1016/S0140-6736(23)02828-3

No abstract available

MeSH terms

Adrenal Gland Neoplasms* / drug therapy
Adrenal Gland Neoplasms* / pathology
Humans
Molecular Medicine
Paraganglioma* / drug therapy
Paraganglioma* / genetics
Paraganglioma* / pathology
Pheochromocytoma* / drug therapy
Pheochromocytoma* / genetics
Pheochromocytoma* / pathology